Zobrazeno 1 - 10
of 1 418
pro vyhledávání: '"Lips, EH"'
Autor:
Byng D; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, PA 3062, The Netherlands., Schaapveld M; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands., van Duijnhoven FH; Division of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, ZA 2333, The Netherlands., van Harten WH; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, PA 3062, The Netherlands., Retèl VP; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, CX 1066, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, PA 3062, The Netherlands.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Dec 16, pp. 1-12. Date of Electronic Publication: 2024 Dec 16.
Autor:
Van Bockstal MR; Department of Pathology, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium. Mieke.VanBockstal@saintluc.uclouvain.be.; Pôle de Morphologie (MORF), Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 10, 1200, Brussels, Belgium. Mieke.VanBockstal@saintluc.uclouvain.be., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands., Smidt M; Department of Surgery, Maastricht University Medical Center, P.O. Box 616, 6200 MD, Maastricht, The Netherlands., Galant C; Department of Pathology, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium.; Pôle de Morphologie (MORF), Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 10, 1200, Brussels, Belgium., van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute Rotterdam, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. c.h.m.vandeurzen@erasmusmc.nl.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Aug 27; Vol. 26 (1), pp. 125. Date of Electronic Publication: 2024 Aug 27.
Autor:
Hutten SJ; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Messal HA; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sheinman M; Oncode Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ciwinska M; Department of Oncology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium., Braams E; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Borden C; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kristel P; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Stoffers S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wessels LF; Oncode Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jonkers J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., van Rheenen J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Scheele CL; Department of Oncology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.
Publikováno v:
The Journal of pathology [J Pathol] 2024 Jul; Vol. 263 (3), pp. 360-371. Date of Electronic Publication: 2024 May 23.
Autor:
Debets DO; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, 3584 CH Utrecht, the Netherlands., de Graaf EL; Pepscope B.V, Nieuwe Kanaal 7, 6709 PA Wageningen, the Netherlands., Liefaard MC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands., Lips EH; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Ressa A; Pepscope B.V, Nieuwe Kanaal 7, 6709 PA Wageningen, the Netherlands., Altelaar M; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, 3584 CH Utrecht, the Netherlands.
Publikováno v:
IScience [iScience] 2024 Apr 30; Vol. 27 (6), pp. 109858. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).
Autor:
Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Voort A; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Seijen M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Thijssen B; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vonk S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mittempergher L; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Bhaskaran R; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Wilrijk, Antwerp, Belgium., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Apr 18; Vol. 10 (1), pp. 29. Date of Electronic Publication: 2024 Apr 18.
Autor:
Alaeikhanehshir S; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Surgery, the Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., Voets MM; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Health Services and Technology Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., van Duijnhoven FH; Department of Surgery, the Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., Lips EH; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, Netherlands., Groen EJ; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, Netherlands., van Oirsouw MCJ; Borstkanker Vereniging Nederland, Utrecht, The Netherlands., Hwang SE; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Lo JY; Department of Radiology, Duke University Medical Center, Durham, NC, USA., Wesseling J; Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Mann RM; Department of Radiology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands., Teuwen J; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands. j.teuwen@nki.nl.; Department of Radiation Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands. j.teuwen@nki.nl.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, USA. j.teuwen@nki.nl.; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. j.teuwen@nki.nl.
Publikováno v:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Apr 05; Vol. 24 (1), pp. 48. Date of Electronic Publication: 2024 Apr 05.
Autor:
Alaeikhanehshir S; Division of Molecular Pathology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Surgical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Ajayi T; European Organisation for Research and Treatment of Cancer EORTC Headquarters, Brussels, Belgium., Duijnhoven FH; Department of Surgical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Poncet C; European Organisation for Research and Treatment of Cancer EORTC Headquarters, Brussels, Belgium., Olaniran RO; European Organisation for Research and Treatment of Cancer EORTC Headquarters, Brussels, Belgium., Lips EH; Division of Molecular Pathology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van 't Veer LJ; Department of Laboratory Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Delaloge S; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Rubio IT; Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Spain., Thompson AM; Dan L Duncan Comprehensive Cancer Centre, Baylor College of Medicine, Houston, TX., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Piccart M; Department of Research, Jules Bordet Institute, Free University of Brussels, Brussels, Belgium., Rutgers EJT; Department of Surgical Oncology, the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 01; Vol. 42 (10), pp. 1124-1134. Date of Electronic Publication: 2024 Jan 19.
Autor:
Alaeikhanehshir S; Division of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, Netherlands.; Department of Surgical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Schmitz RSJM; Division of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, Netherlands., van den Belt-Dusebout AW; Division of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, Netherlands., van Duijnhoven FH; Department of Surgical Oncology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Verschuur E; Borstkanker Vereniging Nederland, Utrecht, The Netherlands., van Seijen M; Division of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, Netherlands., Schaapveld M; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lips EH; Division of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, Netherlands., Wesseling J; Division of Molecular Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX, Netherlands. j.wesseling@nki.nl.; Department of Pathology, the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. j.wesseling@nki.nl.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. j.wesseling@nki.nl.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Feb; Vol. 204 (1), pp. 61-68. Date of Electronic Publication: 2023 Nov 14.
Autor:
Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Netherlands mk.schmidt@nki.nl.; Leiden University Medical Center, Leiden, Netherlands., Lips EH; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Netherlands., Schmitz RS; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Netherlands.; Leiden University Medical Center, Leiden, Netherlands., Verschuur E; Patient author, Precision project, Netherlands., Wesseling J; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Netherlands.; Leiden University Medical Center, Leiden, Netherlands.
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2024 Jan 24; Vol. 384, pp. q22. Date of Electronic Publication: 2024 Jan 24.
Autor:
Aswolinskiy W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Munari E; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Horlings HM; The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Mulder L; The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Bogina G; Pathology Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy., Sanders J; The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Liu YH; The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., van den Belt-Dusebout AW; The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Tessier L; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Center for Integrated Oncology (Institut du cancer de l'Ouest), Angers, France., Balkenhol M; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Stegeman M; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Hoven J; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Wesseling J; The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., van der Laak J; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Lips EH; The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Ciompi F; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands. francesco.ciompi@radboudumc.nl.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2023 Nov 13; Vol. 25 (1), pp. 142. Date of Electronic Publication: 2023 Nov 13.